{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:52:54Z","timestamp":1791006774723,"version":"4.1.0"},"reference-count":61,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.5551\/jat.rv22055","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:12:36Z","timestamp":1782857556000},"page":"1220-1231","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Sinus Rhythm: Rhythm Control and Mechanism-Based Secondary Prevention in Atrial Fibrillation\u2013Related Stroke"],"prefix":"10.5551","volume":"33","author":[{"given":"Yasuhiro","family":"Nishiyama","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences, University of Fukui"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fern\u00e1ndez-Sol\u00e0 J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes De Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundstr\u00f6m J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group: Global burden of cardiovascular diseases and risk factors, 1990-2019. J Am Coll Cardiol, 2020; 76: 2982-3021","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, Aizawa Y, Yamashita T, Atarashi H, Horie M, Ohe T, Doi Y, Shimizu A, Chishaki A, Saikawa T, Yano K, Kitabatake A, Mitamura H, Kodama I, Kamakura S: Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol, 2009; 137: 102-107","DOI":"10.1016\/j.ijcard.2008.06.029"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJL: Worldwide epidemiology of atrial fibrillation. Circulation, 2014; 129: 837-847","DOI":"10.1161\/CIRCULATIONAHA.113.005119"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kornej J, B\u00f6rschel CS, Benjamin EJ, Schnabel RB: Epidemiology of atrial fibrillation in the 21st century. Circ Res, 2020; 127: 4-20","DOI":"10.1161\/CIRCRESAHA.120.316340"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kamel H and Healey JS: Cardioembolic stroke. Circ Res, 2017; 120: 514-526","DOI":"10.1161\/CIRCRESAHA.116.308407"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 1991; 22: 983-988","DOI":"10.1161\/01.STR.22.8.983"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lane DA, Andrade JG, Arbelo E, Boriani G, Hendriks JM, Lee SR, Lip GYH, Mant J, Middeldorp ME: Atrial fibrillation. Lancet, 2026; 407: 1000-1013","DOI":"10.1016\/S0140-6736(25)02166-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D\u2019Agostino RB: Stroke severity in atrial fibrillation. Stroke, 1996; 27: 1760-1764","DOI":"10.1161\/01.STR.27.10.1760"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A: Contribution of atrial fibrillation to incidence and outcome of ischemic stroke. Stroke, 2005; 36: 1115-1119","DOI":"10.1161\/01.STR.0000166053.83476.4a"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Blackshear JL and Odell JA: Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg, 1996; 61: 755-759","DOI":"10.1016\/0003-4975(95)00887-X"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Al-Saady NM, Obel OA, Camm AJ: Left atrial appendage: structure, function, and role in thromboembolism. Heart, 1999; 82: 547-554","DOI":"10.1136\/hrt.82.5.547"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Di Biase LD, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, Horton R, Sanchez JE, Bai R, Mohanty S, Pump A, Cereceda Brantes M, Gallinghouse GJ, Burkhardt JD, Cesarani F, Scaglione M, Natale A, Gaita F: Does the Left Atrial Appendage Morphology Correlate with the Risk of Stroke in Patients with atrial fibrillation?: results from a multicenter study. J Am Coll Cardiol, 2012; 60: 531-538","DOI":"10.1016\/j.jacc.2012.04.032"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D\u2019Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GYH, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S: Atrial cardiomyopathy: definition, characterization, and clinical implications. Europace, 2016; 18: 1455-1490","DOI":"10.1093\/europace\/euw161"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, DeFilippi CR, Gottesman RF, Heckbert SR, Kronmal RA, Soliman EZ, Longstreth WT: Atrial cardiopathy and the risk of ischemic stroke in the CHS (cardiovascular health study). Stroke, 2018; 49: 980-986","DOI":"10.1161\/STROKEAHA.117.020059"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Freedman B, Potpara TS, Lip GYH: Stroke prevention in atrial fibrillation. Lancet, 2016; 388: 806-817","DOI":"10.1016\/S0140-6736(16)31257-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nattel S and Harada M: Atrial remodeling and atrial fibrillation. J Am Coll Cardiol, 2014; 63: 2335-2345","DOI":"10.1016\/j.jacc.2014.02.555"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW: AHA\/ACC\/HRS focused update on atrial fibrillation. J Am Coll Cardiol, 2019; 74: 104-132","DOI":"10.1016\/j.jacc.2019.01.011"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Wagoner DRV; Peer Review Committee Members: ACC\/AHA\/ACCP\/HRS guideline for atrial fibrillation. Circulation, 2024; 149: e1-e156","DOI":"10.1161\/CIR.0000000000001193"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, L\u00f8chen ML, Lumbers RT, Maesen B, M\u00f8lgaard I, Rosano GMC, Sanders P, Schnabel RB, Suwalski P, Svennberg E, Tamargo J, Tica O, Traykov V, Tzeis S, Kotecha D, Dagres N, Rocca B, Ahsan S, Ameri P, Arbelo E, Bauer A, Borger MA, Buccheri S, Casadei B, Chioncel O, Dobrev D, Fauchier L, Gigante B, Glikson M, Hijazi Z, Hindricks G, Husser D, Ibanez B, James S, Kaab S, Kirchhof P, K\u00f8ber L, Koskinas KC, Kumler T, Lip GYH, Mandrola J, Marx N, Mcevoy JW, Mihaylova B, Mindham R, Muraru D, Neubeck L, Nielsen JC, Oldgren J, Paciaroni M, Pasquet AA, Prescott E, Rega F, Rossello FJ, Rucinski M, Salzberg SP, Schulman S, Sommer P, Svendsen JH, Ten Berg JM, Ten Cate H, Vaartjes I, Vrints CJ, Witkowski A, Zeppenfeld K, Simoni L, Kichou B, Sisakian HS, Scherr D, Cools F, Smaji\u0107 E, Shalganov T, Manola S, Avraamides P, Taborsky M, Brandes A, El-Damaty AM, Kampus P, Raatikainen P, Garcia R, Etsadashvili K, Eckardt L, Kallergis E, Gell\u00e9r L, Gu\u00f0mundsson K, Lyne J, Marai I, Colivicchi F, Abdrakhmanov AS, Bytyci I, Kerimkulova A, Kupics K, Refaat M, Bheleel OA, Barysien\u0117 J, Leitz P, Sammut MA, Grosu A, Pavlovic N, Moustaghfir A, Yap SC, Taleski J, Fink T, Kazmierczak J, Sanfins VM, Cozma D, Zavatta M, Kova\u010devi\u0107 DV, Hlivak P, Zupan I, Calvo D, Bj\u00f6rkenheim A, K\u00fchne M, Ouali S, Demircan S, Sychov OS, Ng A, Kuchkarov H: ESC guidelines for atrial fibrillation. Eur Heart J, 2024; 45: 3314-3414","DOI":"10.1093\/eurheartj\/ehae176"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007; 146: 857-867","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L: Dabigatran versus warfarin in atrial fibrillation. N Engl J Med, 2009; 361: 1139-1151","DOI":"10.1056\/NEJMoa0905561"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KAA, Califf RM: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med, 2011; 365: 883-891","DOI":"10.1056\/NEJMoa1009638"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FWA, Zhu J, Wallentin L: Apixaban versus warfarin in atrial fibrillation. N Engl J Med, 2011; 365: 981-992","DOI":"10.1056\/NEJMoa1107039"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, \u0160pinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM: Edoxaban versus warfarin in atrial fibrillation. N Engl J Med, 2013; 369: 2093-2104","DOI":"10.1056\/NEJMoa1310907"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, Bradley SM, Maddox TM, Grunwald GK, Bar\u00f3n AE, Rumsfeld JS, Varosy PD, Schneider PM, Marzec LN, Ho PM: Adherence to dabigatran therapy and longitudinal outcomes. Am Heart J, 2014; 167: 810-817","DOI":"10.1016\/j.ahj.2014.03.023"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA: Non-Vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. J Am Coll Cardiol, 2017; 69: 2779-2790","DOI":"10.1016\/j.jacc.2017.03.600"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, Jackevicius CA: Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes, 2020; 13: e005969","DOI":"10.1161\/CIRCOUTCOMES.119.005969"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron, J.C. Kellen, H.L. Greene, M.C. Mickel, J.E. Dalquist, and S.D. Corley: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002; 347: 1825-1833","DOI":"10.1056\/NEJMoa021328"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns HJGM: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med, 2002; 347: 1834-1840","DOI":"10.1056\/NEJMoa021375"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JMO, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O\u2019Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL: Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med, 2008; 358: 2667-2677","DOI":"10.1056\/NEJMoa0708789"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, Van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidb\u00fcchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G: Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med, 2020; 383: 1305-1316","DOI":"10.1056\/NEJMoa2019422"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Jensen M, Suling A, Metzner A, Schnabel RB, Borof K, Goette A, Haeusler KG, Zapf A, Wegscheider K, Fabritz L, Diener HC, Thomalla G, Kirchhof P: Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: EAST-AFNET 4 subgroup analysis. Lancet Neurol, 2023; 22: 45-54","DOI":"10.1016\/S1474-4422(22)00436-7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kim D, Yang PS, You SC, Jang E, Yu HT, Kim TH, Pak HN, Lee MH, Lip GYH, Sung JH, Joung B: Comparative effectiveness of early rhythm control versus rate control for cardiovascular outcomes in patients with atrial fibrillation. J Am Heart Assoc, 2021; 10: e023055","DOI":"10.1161\/JAHA.121.023055"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Proietti M, Vitolo M, Harrison SL, Lane DA, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Boriani G, Lip GYH: Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry. Clin Res Cardiol, 2022; 111: 70-84","DOI":"10.1007\/s00392-021-01914-y"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Seiffge DJ, De Marchis GM, Koga M, Paciaroni M, Wilson D, Cappellari M, Macha, MD K, Tsivgoulis G, Ambler G, Arihiro S, Bonati LH, Bonetti B, Kallm\u00fcnzer B, Muir KW, Bovi P, Gensicke H, Inoue M, Schwab S, Yaghi S, Brown MM, Lyrer P, Takagi M, Acciarrese M, Jager HR, Polymeris AA, Toyoda K, Venti M, Traenka C, Yamagami H, Alberti A, Yoshimura S, Caso V, Engelter ST, Werring DJ: Ischemic stroke despite oral anticoagulant therapy in atrial fibrillation. Ann Neurol, 2020; 87: 677-687","DOI":"10.1002\/ana.25700"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Polymeris AA, Meinel TR, Oehler H, H\u00f6lscher K, Zietz A, Scheitz JF, Nolte CH, Stretz C, Yaghi S, Stoll S, Wang R, H\u00e4usler KG, Hellwig S, Klammer MG, Litmeier S, Leon Guerrero CR, Moeini-Naghani I, Michel P, Strambo D, Salerno A, Bianco G, Cereda C, Uphaus T, Gr\u00f6schel K, Katan M, Wegener S, Peters N, Engelter ST, Lyrer PA, Bonati LH, Grunder L, Ringleb PA, Fischer U, Kallm\u00fcnzer B, Purrucker JC, Seiffge DJ: Aetiology, secondary prevention strategies and outcomes of ischemic stroke despite oral anticoagulation. J Neurol Neurosurg Psychiatry, 2022; 93: 588-598","DOI":"10.1136\/jnnp-2021-328391"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Hindsholm MF, Rodr\u00edguez LAG, Brandes A, Hallas J, H\u00f8yer BB, M\u00f6ller S, Gurol ME, Simonsen CZ, Gaist D: Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants. JAMA Neurol, 2024; 81: 805-813","DOI":"10.1001\/jamaneurol.2024.1892"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Meinel TR, Branca M, De Marchis GM, Nedeltchev K, Kahles T, Bonati L, Arnold M, Heldner MR, Jung S, Carrera E, Dirren E, Michel P, Strambo D, Cereda CW, Bianco G, K\u00e4gi G, Vehoff J, Katan M, Bolognese M, Backhaus R, Salmen S, Albert S, Medlin F, Berger C, Schelosky L, Renaud S, Niederhauser J, Bonvin C, Schaerer M, Mono ML, Rodic B, Tarnutzer AA, Mordasini P, Gralla J, Kaesmacher J, Engelter S, Fischer U, Seiffge DJ: Prior anticoagulation in ischemic stroke and atrial fibrillation. Ann Neurol, 2021; 89: 42-53","DOI":"10.1002\/ana.25917"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP: Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes. J Am Coll Cardiol, 2016; 68: 2597-2604","DOI":"10.1016\/j.jacc.2016.09.966"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Yaghi S, Song C, Gray WA, Furie KL, Elkind MSV, Kamel H: Left atrial appendage function and stroke risk. Stroke, 2015; 46: 3554-3559","DOI":"10.1161\/STROKEAHA.115.011273"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Foschi M, De Santis F, Gabriele F, Ornello R, D\u2019Anna L, Zini A, Paolucci M, Forlivesi S, Migliaccio L, Viola MM, Cascio Rizzo A, Sessa M, Schwarz G, Tortorella R, Banerjee S, Desai G, Ahmed KF, Prandin G, Pantoni L, Mele F, Scopelliti G, Cova I, Valente M, Maisano D, Antonelli L, Bagnato MR, Di Mauro G, Bernocchi F, Di Donna MG, Casolla B, Mazloum P, Campisi C, Caraux A, Gonz\u00e1lez-Mart\u00edn L, Rigual R, Fuentes B, Herv\u00e1s-Testal C, Candelaresi P, Andreone V, De Mase A, Spina E, Aguiar De Sousa D, Souza MA, Fior A, Ser\u00f4dio M, Caliandro P, Zauli A, Reale G, Abdelalim A, Ahmed S, Ismail SA, Zhang L, Latimer T, Elboghdady M, Elbassiouny A, Roushdy T, Shokri H, Ferrari F, Loizzo ND, Mazzacane F, Guarino M, Barone V, Forti P, Rinaldi G, Rossi MV, Laterza V, Frisullo G, Rizzo PA, Broccolini A, Mannino M, Terruso V, Caggiula M, Rizzo A, Fonseca AC, Antunes B, Barbosa AM, Budincevic H, Crnac P, Viticchi G, Silvestrini M, Barba L, Musienko V, Otto M, Lochner P, Landau B, Buddha S, Khalil R, Piscaglia MG, Minguzzi E, Zedde M, Nasreldein A, Vinciguerra L, Costa LR, Elsayed AE, AlBanna M, Tudisco L, Mosconi MG, Polymeris AA, Merlino G, Sacco S: Competing stroke etiologies and outcomes after breakthrough ischemic stroke on oral anticoagulants in patients with atrial fibrillation. Neurology, 2026; 106: e214758","DOI":"10.1212\/WNL.0000000000214758"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Ntaios G: Embolic stroke of undetermined source. J Am Coll Cardiol, 2020; 75: 333-340","DOI":"10.1016\/j.jacc.2019.11.024"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Camm AJ, Naccarelli GV, Mittal S, Crijns HJGM, Hohnloser SH, Ma CS, Natale A, Turakhia MP, Kirchhof P: The increasing role of rhythm control in patients with atrial fibrillation. J Am Coll Cardiol, 2022; 79: 1932-1948","DOI":"10.1016\/j.jacc.2022.03.337"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M: Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone for the management of atrial fibrillation. Europace, 2011; 13: 329-345","DOI":"10.1093\/europace\/euq450"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, D\u2019Avila A, De Groot NMS, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T: 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm, 2017; 14: e275-e444","DOI":"10.1016\/j.hrthm.2017.05.012"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Wazni OM, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S, Niebauer M, Makati K, Halperin B, Gauri A, Morales G, Shao M, Cerkvenik J, Kaplon RE, Nissen SE: Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med, 2021; 384: 316-324","DOI":"10.1056\/NEJMoa2029554"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, Roux JF, Yung D, Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Lauck S, Macle L, Verma A: Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med, 2021; 384: 305-315","DOI":"10.1056\/NEJMoa2029980"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, B\u00e4nsch D: Catheter ablation for atrial fibrillation with heart failure. N Engl J Med, 2018; 378: 417-427","DOI":"10.1056\/NEJMoa1707855"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL: Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. JAMA, 2019; 321: 1261-1274","DOI":"10.1001\/jama.2019.0693"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Bunch TJ, May HT, Bair TL, Weiss JP, Crandall BG, Osborn JS, Mallender C, Anderson JL, Muhlestein BJ, Lappe DL, Day JD: Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm, 2013; 10: 1272-1277","DOI":"10.1016\/j.hrthm.2013.07.002"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Noseworthy PA, Kapa S, Deshmukh AJ, Madhavan M, Van Houten H, Haas LR, Mulpuru SK, McLeod CJ, Asirvatham SJ, Friedman PA, Shah ND, Packer DL: Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: a propensity-matched study of 24,244 patients. Heart Rhythm, 2015; 12: 1154-1161","DOI":"10.1016\/j.hrthm.2015.02.020"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Friberg L, Tabrizi F, Englund A: Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J, 2016; 37: 2478-2487","DOI":"10.1093\/eurheartj\/ehw087"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Kimura K, Nishiyama Y, Iwasaki Y-K, Shimizu W, Toyoda K, Sakamoto Y, Katano T, Yamamoto T, Takeuchi M, Kumagai K, Tsuto K, Sugi K, Kusano K, Koga M, Okubo S, Sato T, Hamaguchi H, Yoshida A, Kuriki A, Tanno K, Kitagawa K, Hagiwara N, Daida H, Iguchi Y, Fujimoto S, Miyamoto S, Fukuzawa M, Sugimoto M, Takita A, Otsuka T, Okumura K: Catheter ablation and oral anticoagulation for secondary stroke prevention in atrial fibrillation: the STABLED randomized clinical trial. JAMA Neurol, 2026; 83: 329-338","DOI":"10.1001\/jamaneurol.2026.0155"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet, 2009; 374: 534-542","DOI":"10.1016\/S0140-6736(09)61343-X"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY: Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy. J Am Coll Cardiol, 2014; 64: 1-12","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M, Reents W, Budera P, Baddour AJ, Fila P, Devereaux PJ, Bogachev-Prokophiev A, Boening A, Teoh KHT, Tagarakis GI, Slaughter MS, Royse AG, McGuinness S, Alings M, Punjabi PP, Mazer CD, Folkeringa RJ, Colli A, Avezum \u00c1, Nakamya J, Balasubramanian K, Vincent J, Voisine P, Lamy A, Yusuf S, Connolly SJ: Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med, 2021; 384: 2081-2091","DOI":"10.1056\/NEJMoa2101897"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Wazni OM, Saliba WI, Nair DG, Marijon E, Schmidt B, Hounshell T, Ebelt H, Skurk C, Oza S, Patel C, Kanagasundram A, Sadhu A, Sundaram S, Osorio J, Mark G, Gupta M, DeLurgio DB, Olson J, Nielsen-Kudsk JE, Boersma LVA, Healey JS, Phillips KP, Asch FM, Wolski K, Roy K, Christen T, Sutton BS, Stein KM, Reddy VY: Left atrial appendage closure after ablation for atrial fibrillation. N Engl J Med, 2025; 392: 1277-1287","DOI":"10.1056\/NEJMoa2408308"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Doshi SK, Kar S, Nair DG, Waggoner T, Agarwal H, Moussavian M, Kashani A, Oza S, Feldman L, Sadhu A, DeLurgio D, Alli O, Nielsen-Kudsk JEN, Yamamoto M, Alkhouli M, Camm AJ, Coylewright M, Gibson CM, Granger CB, Gurol ME, Huber KC, Mansour M, Natale A, Pocock SJ, Reddy VY, Saliba, Asch FM, Wehrenberg S, Frost K, Christen T, Sutton BS, Stein KM, Leon MB, Ellenbogen KA; CHAMPION-AF Investigators: Left atrial appendage closure or anticoagulation for atrial fibrillation: CHAMPION-AF. N Engl J Med, 2026; 394: 2083-2094","DOI":"10.1056\/NEJMoa2517213"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Landmesser U, Skurk C, Kirchhof P, Lewalter T, Hartung J, Rroku A, Pieske B, Brachmann J, Akin I, Jacobshagen C, Meder B, Zeiher A, Anker SD, Thiele H, Blankenberg S, Massberg S, Schunkert H, Frey N, Joost A, Bergmann M, Von Bardeleben RS, Friede T, Placzek M, Suling A, Haeusler KG, Endres M, Wegscheider K, Boldt LH, Eitel I: Left atrial appendage closure or medical therapy in atrial fibrillation. N Engl J Med, 2026; 394: 1270-1280","DOI":"10.1056\/NEJMoa2513310"},{"key":"60","unstructured":"60) LAAOS-4 Investigators. The Fourth Left Atrial Appendage Occlusion Study, ClinicalTrials.gov, ID: NCT05963698"},{"key":"61","unstructured":"61) ClinicalTrials.gov: Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute Stroke (EAST-STROKE). ClinicalTrials.gov identifier: NCT05293080"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/10\/33_RV22055\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:02:43Z","timestamp":1791003763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/10\/33_RV22055\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22055","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"RV22055"}}